ID
36532
Description
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT02328950
Lien
https://clinicaltrials.gov/show/NCT02328950
Mots-clés
Versions (1)
- 20/05/2019 20/05/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
20 mai 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Myelodysplastic Syndromes NCT02328950
Eligibility Myelodysplastic Syndromes NCT02328950
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Pregnancy | Breast Feeding
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Study Subject Participation Status
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Medical contraindication Investigational New Drug
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0013230
Description
Comorbidity Severe | Investigational New Drugs At risk | Organ dysfunction Serious | Disease Serious | Heart Disease | Kidney Disease | Liver disease | Organ system Disease
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0205082
- UMLS CUI [2,1]
- C0013230
- UMLS CUI [2,2]
- C1444641
- UMLS CUI [3,1]
- C0349410
- UMLS CUI [3,2]
- C0205404
- UMLS CUI [4,1]
- C0012634
- UMLS CUI [4,2]
- C0205404
- UMLS CUI [5]
- C0018799
- UMLS CUI [6]
- C0022658
- UMLS CUI [7]
- C0023895
- UMLS CUI [8,1]
- C0460002
- UMLS CUI [8,2]
- C0012634
Similar models
Eligibility Myelodysplastic Syndromes NCT02328950
- StudyEvent: Eligibility
C1515568 (UMLS CUI [1,2])
C4302097 (UMLS CUI [2,1])
C1515568 (UMLS CUI [2,2])
C1142169 (UMLS CUI [3])
C0023449 (UMLS CUI [4,1])
C2945760 (UMLS CUI [4,2])
C0023467 (UMLS CUI [5,1])
C4319571 (UMLS CUI [5,2])
C0023467 (UMLS CUI [6,1])
C0677874 (UMLS CUI [6,2])
C0205435 (UMLS CUI [6,3])
C0023449 (UMLS CUI [7,1])
C4319571 (UMLS CUI [7,2])
C0023449 (UMLS CUI [8,1])
C0677874 (UMLS CUI [8,2])
C0205435 (UMLS CUI [8,3])
C0205179 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0013230 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0349410 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0012634 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C0018799 (UMLS CUI [5])
C0022658 (UMLS CUI [6])
C0023895 (UMLS CUI [7])
C0460002 (UMLS CUI [8,1])
C0012634 (UMLS CUI [8,2])